JPH08506812A - 抗腫瘍剤としてのアシルフルベン類似体 - Google Patents
抗腫瘍剤としてのアシルフルベン類似体Info
- Publication number
- JPH08506812A JPH08506812A JP6518208A JP51820894A JPH08506812A JP H08506812 A JPH08506812 A JP H08506812A JP 6518208 A JP6518208 A JP 6518208A JP 51820894 A JP51820894 A JP 51820894A JP H08506812 A JPH08506812 A JP H08506812A
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- cells
- irudin
- cell
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/94—Spiro compounds containing "free" spiro atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.被検者における腫瘍細胞増殖を阻害する方法であって、下記構造: を有するアシルフルベン類似体の治療量と前記腫瘍を接触させることを含んで成 り、ここで前記類似体は被検者に対する過剰な毒性を伴わずに腫瘍増殖を阻害す ることができ、そしてRは (R1=アルキル、アリール、NH2、NHRまたはNR2)から成る群より選択 される、腫瘍増殖を阻害する方法。 2.前記治療量が、静脈内投与で30〜112,000μg/kg体重である、請求項1の 方法。 3.前記治療量が、腹腔内投与で300〜112,000μg/kg体重である、請求項1 の方法。 4.前記類似体が静脈内、経口、腹腔内および吸入から選択された任意の手段 により投与される、請求項1の方法。 5.腫瘍抗原に結合することができる組成物であって、下記構造: 〔ここで、Rは (R1=アルキル、アリール、NH2、NHRまたはNR2)から成る群より選択 される〕 を有するアシルフルベン類似体に取り付けられた試薬を含んで成る組成物。 6.前記試薬が抗体である、請求項5の複合体。 7.被検者における腫瘍細胞増殖を阻害する方法であって、腫瘍を請求項6の 組成物と接触させることを含んで成る方法。 8.30〜100mgの請求項1の化合物と医薬上許容される担体を含んで成る治療 用組成物。 9.前記腫瘍細胞が骨髄性白血病、類表皮腫およびT細胞性白血病、並びに肺 癌、卵巣癌および乳癌から成る群より選択される、請求項1の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/015,179 | 1993-02-09 | ||
US08/015,179 US5439936A (en) | 1989-10-03 | 1993-02-09 | Method of treating certain tumors using illudin analogs |
PCT/US1994/001232 WO1994018151A1 (en) | 1993-02-09 | 1994-02-02 | Acylfulvene analogues as antitumor agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08506812A true JPH08506812A (ja) | 1996-07-23 |
JP3908270B2 JP3908270B2 (ja) | 2007-04-25 |
Family
ID=21769946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51820894A Expired - Fee Related JP3908270B2 (ja) | 1993-02-09 | 1994-02-02 | アシルフルベン類似体およびその医薬組成物 |
Country Status (22)
Country | Link |
---|---|
US (3) | US5439936A (ja) |
EP (1) | EP0683762B1 (ja) |
JP (1) | JP3908270B2 (ja) |
KR (1) | KR100311327B1 (ja) |
CN (1) | CN1046934C (ja) |
AT (1) | ATE174894T1 (ja) |
AU (1) | AU676889B2 (ja) |
BR (1) | BR9405689A (ja) |
CA (1) | CA2155329C (ja) |
CZ (1) | CZ288596B6 (ja) |
DE (1) | DE69415507T2 (ja) |
DK (1) | DK0683762T3 (ja) |
ES (1) | ES2125441T3 (ja) |
GR (1) | GR3029736T3 (ja) |
HU (1) | HU220059B (ja) |
MD (1) | MD1418G2 (ja) |
NO (1) | NO318648B1 (ja) |
NZ (1) | NZ262282A (ja) |
PL (1) | PL175024B1 (ja) |
RU (1) | RU2145849C1 (ja) |
TJ (1) | TJ266B (ja) |
WO (1) | WO1994018151A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002503714A (ja) * | 1998-02-20 | 2002-02-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 抗腫瘍剤 |
US7655695B2 (en) | 2005-08-03 | 2010-02-02 | The Regents Of The University Of California | Illudin analogs useful as anticancer agents |
US7713939B2 (en) | 1996-07-18 | 2010-05-11 | The Regents Of The University Of California | Illudin analogs useful as antitumor agents |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723632A (en) * | 1996-08-08 | 1998-03-03 | Mgi Pharma, Inc. | Total synthesis of antitumor acylfulvenes |
US7141603B2 (en) * | 1999-02-19 | 2006-11-28 | The Regents Of The University California | Antitumor agents |
US6436916B1 (en) | 2000-10-12 | 2002-08-20 | Alvin Guttag | Ibuprofen-aspirin and hydroxymethylacylfulvene analogs |
US7015247B2 (en) * | 2000-10-12 | 2006-03-21 | Alvin Guttag | Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs |
WO2006002422A2 (en) | 2004-06-24 | 2006-01-05 | Novartis Vaccines And Diagnostics Inc. | Compounds for immunopotentiation |
WO2010085811A2 (en) * | 2009-01-26 | 2010-07-29 | Taipei Medical University | Use of pterosin compounds for treating diabetes and obesity |
US10285955B2 (en) | 2014-04-10 | 2019-05-14 | Af Chemicals, Llc | Affinity medicant conjugate |
US11135182B2 (en) | 2014-04-10 | 2021-10-05 | Af Chemicals, Llc | Affinity medicant conjugates |
CA2944699C (en) | 2014-04-10 | 2023-05-23 | Af Chemicals, Llc | Affinity medicant conjugates |
CN106083953A (zh) * | 2016-06-15 | 2016-11-09 | 成都医学院 | 一种从蕨菜中提取原蕨苷以及制备高纯度原蕨苷的方法 |
WO2018170230A1 (en) * | 2017-03-15 | 2018-09-20 | Memorial Sloan Kettering Cancer Center | Diagnosis & treatment of ercc3-mutant cancer |
KR20210087435A (ko) * | 2018-09-04 | 2021-07-12 | 랜턴 파마 인코포레이티드 | 일루딘 유사체, 이의 용도, 및 이의 합성 방법 |
US11160807B1 (en) | 2018-12-11 | 2021-11-02 | Af Chemicals, Llc | Methods, compositions and devices for treating cancer with illudofulvenes |
RU2738848C1 (ru) * | 2019-10-24 | 2020-12-17 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида |
EP4035684A1 (en) | 2019-11-25 | 2022-08-03 | AF Chemical LLC | Affinity illudofulvene conjugates |
US11591295B2 (en) | 2019-11-25 | 2023-02-28 | Af Chemicals Llc | Affinity illudofulvene conjugates |
CN112972443A (zh) * | 2021-03-29 | 2021-06-18 | 杭州添帆生物科技有限公司 | 一种抗癌药物及其应用 |
WO2023239821A2 (en) * | 2022-06-07 | 2023-12-14 | Lantern Pharma Inc. | Treating cancers with combinations of acylfulvenes with ibrutinib or bortezomib |
WO2024016014A2 (en) * | 2022-07-15 | 2024-01-18 | Lantern Pharma Inc. | Method for treating breast cancers and parp resistant breast cancers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0565519T3 (da) * | 1989-10-03 | 1996-09-23 | Univ California | Illudinanaloge som antitumormidler |
GB9017024D0 (en) * | 1990-08-03 | 1990-09-19 | Erba Carlo Spa | New linker for bioactive agents |
FI85318C (fi) * | 1990-08-14 | 1992-03-25 | Tecnomen Oy | Kompensering av felet i en klockas gaong. |
JPH06223404A (ja) * | 1993-01-25 | 1994-08-12 | Mitsubishi Kasei Corp | 光学的情報記録用媒体 |
-
1993
- 1993-02-09 US US08/015,179 patent/US5439936A/en not_active Expired - Lifetime
-
1994
- 1994-02-02 WO PCT/US1994/001232 patent/WO1994018151A1/en active IP Right Grant
- 1994-02-02 TJ TJ96000336A patent/TJ266B/xx unknown
- 1994-02-02 BR BR9405689A patent/BR9405689A/pt not_active Application Discontinuation
- 1994-02-02 MD MD96-0212A patent/MD1418G2/ro not_active IP Right Cessation
- 1994-02-02 HU HU9502358A patent/HU220059B/hu not_active IP Right Cessation
- 1994-02-02 DE DE69415507T patent/DE69415507T2/de not_active Expired - Lifetime
- 1994-02-02 EP EP94908702A patent/EP0683762B1/en not_active Expired - Lifetime
- 1994-02-02 ES ES94908702T patent/ES2125441T3/es not_active Expired - Lifetime
- 1994-02-02 CA CA002155329A patent/CA2155329C/en not_active Expired - Fee Related
- 1994-02-02 AU AU61700/94A patent/AU676889B2/en not_active Ceased
- 1994-02-02 CN CN94191560A patent/CN1046934C/zh not_active Expired - Fee Related
- 1994-02-02 AT AT94908702T patent/ATE174894T1/de not_active IP Right Cessation
- 1994-02-02 JP JP51820894A patent/JP3908270B2/ja not_active Expired - Fee Related
- 1994-02-02 DK DK94908702T patent/DK0683762T3/da active
- 1994-02-02 KR KR1019950703280A patent/KR100311327B1/ko not_active IP Right Cessation
- 1994-02-02 CZ CZ19951986A patent/CZ288596B6/cs not_active IP Right Cessation
- 1994-02-02 NZ NZ262282A patent/NZ262282A/en not_active IP Right Cessation
- 1994-02-02 PL PL94310159A patent/PL175024B1/pl not_active IP Right Cessation
- 1994-02-02 RU RU95121694A patent/RU2145849C1/ru not_active IP Right Cessation
- 1994-07-15 US US08/276,169 patent/US5563176A/en not_active Expired - Lifetime
- 1994-11-01 US US08/332,940 patent/US5523490A/en not_active Expired - Lifetime
-
1995
- 1995-08-07 NO NO19953099A patent/NO318648B1/no not_active IP Right Cessation
-
1999
- 1999-03-19 GR GR990400821T patent/GR3029736T3/el unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713939B2 (en) | 1996-07-18 | 2010-05-11 | The Regents Of The University Of California | Illudin analogs useful as antitumor agents |
JP2002503714A (ja) * | 1998-02-20 | 2002-02-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 抗腫瘍剤 |
US7655695B2 (en) | 2005-08-03 | 2010-02-02 | The Regents Of The University Of California | Illudin analogs useful as anticancer agents |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH08506812A (ja) | 抗腫瘍剤としてのアシルフルベン類似体 | |
US8394816B2 (en) | Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia | |
JPS59225150A (ja) | 殺生物性芳香族化合物、その合成および医薬としてのその使用 | |
JP4583598B2 (ja) | エクテイナシジン743の代謝産物 | |
JP4372843B2 (ja) | 坑腫瘍剤として有用なイルジン類似体 | |
US6599938B1 (en) | Compounds having MIF antagonist activity | |
DE69907419T2 (de) | Antitumorwirkstoffe | |
EP0565519B1 (en) | Illudin analogs as anti-tumor agents | |
JPH0296523A (ja) | 白金化学療法生成物 | |
CN110590850B (zh) | 一种抗急性髓系白血病的化合物及其制备方法与应用 | |
JPH02502543A (ja) | 新規6置換マイトマイシン類似体 | |
US20190077808A1 (en) | 4-azapodophylotoxins compounds | |
EP1720849B1 (fr) | Derives de pyranone utiles pour le traitement du cancer | |
JP2002509532A (ja) | アルグラビン(arglabin)およびアルグラビン誘導体の薬学的組成物 | |
JPH11504041A (ja) | 多発性硬化症の治療に有用な生物学上活性なウレイド誘導体 | |
EP0042348A1 (fr) | Dérivés de l'olivacine et leur application thérapeutique | |
KR20230035347A (ko) | 개질된 단당류 화합물을 사용하는 암 치료 방법 | |
FR2790954A1 (fr) | Composition pharmaceutique a base de composes polyaromatiques | |
JPS63227526A (ja) | 親脂性アントラサイクリンを含有する薬剤およびその製法 | |
JPS61197547A (ja) | 新規2−ニトロソベンゾフエノン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041221 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050318 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050509 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051101 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060131 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060320 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060501 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20061219 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070118 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |